RLFTF News and Press, Mondobiotech Holding AG Basel From 04/14/23

2023-04-14 04:58:57 ET Relief Therapeutics Holding AG press release ( OTCQB:RLFTF ): FY GAAP EPS of CHF0.012. As of December 2022 had CHF22.56M in cash and cash equivalents. For further details see: Relief Therapeutics GAAP EPS of CHF0.01

GENEVA, SWITZERLAND / ACCESSWIRE / April 3, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief Therapeutics, or Relief), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benef...

GENEVA, SWITZERLAND / ACCESSWIRE / April 5, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) ("Relief Therapeutics" or the "Company"), a biopharmaceutical company committed to advancing treatment paradigms to benefit the lives of patients living with rare disease...

Proposes a reverse stock split of its ordinary shares in preparation for planned listing to the Nasdaq Stock Market GENEVA, SWITZERLAND / ACCESSWIRE / April 4, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) ("Relief Therapeutics" or the "Company"), a biopha...

Dr. Gao has made foundational contributions in the discovery and characterization of adeno-associated virus (AAV) serotypes which were instrumental in the resurgence of gene therapy GENEVA, SWITZERLAND / ACCESSWIRE / April 3, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )...

Acer Therapeutics reports data from a survey of UCD healthcare providers show taste and odor are the most important attributes when considering treatment options and adherence GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )( OTCQB: RLFTF )(...

The results of the preclinical study demonstrate improved muscle anabolism and function with a prolonged-release amino acid supplement using Physiomimic Technology™ GENEVA, SWITZERLAND / ACCESSWIRE / March 17, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF) (OTCQB:RLFTF) (...

The Company also discloses it has transferred most of the funds it held with Credit Suisse and has no funds with recently closed U.S. banks GENEVA, SWITZERLAND / ACCESSWIRE / March 16, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )( OTCQB: RLFTF )( OTCQB : RLFTY ) ("Relief Therapeu...

Paolo Galfetti, chief operating officer of Relief Therapeutics and chief executive officer of APR Applied Pharma Research SA, shares his family's rare story of living with phenylketonuria GENEVA, SWITZERLAND / ACCESSWIRE / February 28, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OT...

GENEVA, SWITZERLAND / ACCESSWIRE / February 14, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(ORCQB: RLFTY ) ("Relief Therapeutics" or the "Company"), a biopharmaceutical company developing and commercializing novel, patent-protected products in select specialty and rare dis...